Korean Biotechnology Company Sequences Genome of Korean Man | GenomeWeb

NEW YORK, June 27 - Macrogen, a Korean biotechnology company, has sequenced its own draft of the human genome using the DNA of a 22 year-old Korean man, The Korea Times reported Wednesday.

After sequencing the DNA, Macrogen compared the 96,768 BAC clones that the company collected with Celera's version of the human genome, published last February in Science . Macrogen officials claimed to have found specific genes unique to the Korean population.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.